Core Viewpoint - The acquisition of 100% equity in Changsha Zhongya Medical Imaging Diagnosis Co., Ltd. by Hunan Yimai, a subsidiary of Yimai Sunshine, aims to enhance market position and create synergies in the medical imaging sector in Central China [1][2]. Group 1: Acquisition Details - Yimai Sunshine announced the acquisition of 100% equity in Zhongya Diagnosis for a total price of 29.5 million yuan [1]. - Following the acquisition, Zhongya Diagnosis will become a wholly-owned subsidiary of Hunan Yimai, allowing for the integration of Yimai's product system with Zhongya's business foundation [1][2]. Group 2: Strategic Goals - The acquisition is part of Yimai Sunshine's strategy to leverage its established product offerings and Zhongya's operational strengths to achieve breakthrough performance in the imaging centers [1][2]. - Yimai Sunshine aims to integrate standardized products into existing collaborations with provincial top-tier hospitals, enabling zero customer acquisition costs for revenue generation [2]. Group 3: Company Background and Market Position - Zhongya Diagnosis specializes in early screening and diagnosis of various diseases, including tumors and cardiovascular conditions, and has established long-term partnerships with top hospitals in Hunan [2]. - Yimai Sunshine operates 106 imaging centers across 16 provinces, significantly exceeding competitors in terms of operational scale and regional coverage [3]. Group 4: Management Confidence - The company's management, including the chairman and two executive directors, has committed not to sell shares until December 31, reflecting confidence in the company's future prospects [4].

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性 或完整性亦不發表任何聲明，並明確表示，概不就因本公告全部或任何部分內容所產生或因依 賴該等內容而引致的任何損失承擔任何責任。 Jiangxi Rimag Group Co., Ltd. 江西一脈陽光集團股份有限公司 （於中華人民共和國註冊成立的股份有限公司） （股份代號：2522） 自願公告 收購眾雅診斷股權 本公告由江西一脈陽光集團股份有限公司（「本公司」，連同其附屬公司統稱為「本 集團」）董事（「董事」）會（「董事會」）自願作出，以通知本公司股東（「股東」）及本 公司的潛在投資者有關本集團的最新業務發展。 董事會欣然宣佈，於2025年6月9日（交易時段後），本公司擁有55.0%權益的附屬 公司湖南一脈陽光醫學影像診斷中心有限公司（「湖南一脈」）（作為買方）、長沙市 眾雅健康產業集團有限公司（作為賣方，「賣方」）與長沙眾雅醫學影像診斷有限公 司（「眾雅診斷」）訂立股權轉讓協議（「股權轉讓協議」），據此，湖南一脈將向賣方 收購眾雅診斷的100.0%股權（「收購事項」），總代價為人民幣29,500,000元。 於本公告日期，湖南 ...